# Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer

> **NCT02955173** · NA · COMPLETED · sponsor: **Qilu Hospital of Shandong University** · enrollment: 467 (actual)

## Conditions studied

- Circulating Tumor Cells
- Colorectal Cancer
- Gastric Cancer

## Interventions

- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT02955173
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2020-12-14
- **Final completion:** 2021-08-03
- **Target enrollment:** 467 (ACTUAL)
- **Last updated:** 2021-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02955173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02955173, "Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02955173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*